You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00904-6766


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00904-6766

Drug Name NDC Price/Unit ($) Unit Date
CHLD ACETAMINOPHEN 160 MG/5 ML 00904-6766-20 0.02113 ML 2024-12-18
CHLD ACETAMINOPHEN 160 MG/5 ML 00904-6766-20 0.02052 ML 2024-11-20
CHLD ACETAMINOPHEN 160 MG/5 ML 00904-6766-20 0.02152 ML 2024-10-23
CHLD ACETAMINOPHEN 160 MG/5 ML 00904-6766-20 0.02214 ML 2024-09-18
CHLD ACETAMINOPHEN 160 MG/5 ML 00904-6766-20 0.02176 ML 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00904-6766

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00904-6766 Market Analysis and Financial Projection

Market Analysis and Price Projections for Acetaminophen (NDC: 0904-6766)

Market Overview

The global acetaminophen market, which includes the product identified by the NDC code 0904-6766, is a significant segment within the pharmaceutical industry. As of 2022, the global acetaminophen market was valued at USD 9.8 billion and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.2% to reach USD 15.2 billion by 2033[1].

Key Drivers of Demand

The demand for acetaminophen is driven by several factors, including the increasing prevalence of chronic illnesses such as cancer and chronic obstructive pulmonary disease (COPD). Additionally, the need for effective pain management, particularly in post-operative care and the management of opioid tolerance, is a significant driver. Many individuals who become opioid-tolerant seek alternative pain relief options, making acetaminophen a preferred choice[1].

Market Segmentation

Route of Administration

The oral route of administration dominates the acetaminophen market, accounting for approximately 92.4% of the market share in 2022. This is due to the ease of administration and the widespread acceptance of oral medications[1].

Geographical Distribution

The Asia-Pacific region, particularly India and China, is a key market for acetaminophen due to rapid economic growth and an increasing demand for pain relief medications. North America and Europe also hold significant market shares, with acetaminophen maintaining a market share of about 62.1% in these regions in 2023[1].

Price Trends and Projections

Historical Pricing

The prices of prescription drugs, including acetaminophen, have historically increased faster than the rate of general inflation. For example, retail prices for commonly used drugs have consistently risen above inflation rates from 2006 to 2020[2].

Future Projections

While specific price projections for the NDC code 0904-6766 are not available, the overall acetaminophen market is expected to see stable growth. The market value is projected to increase from USD 9.8 billion in 2022 to USD 15.2 billion by 2033, indicating a steady demand and potentially stable pricing trends[1].

Regulatory and Legislative Impact

Drug Pricing Legislation

Recent legislative changes, such as the updated Senate drug pricing legislation, could impact the pricing of prescription drugs, including acetaminophen. These laws aim to reduce manufacturer revenues through Medicare negotiation and penalties for non-compliance, which could influence the pricing strategies of pharmaceutical companies[4].

Competitive Landscape

The acetaminophen market is highly competitive, with key players including Pfizer Inc., Sanofi, Janssen Pharmaceuticals, Bayer AG, GlaxoSmithKline plc, and others. These companies are likely to adjust their pricing strategies based on market demand, regulatory changes, and competitive pressures[1].

Impact of COVID-19

The COVID-19 pandemic had a significant impact on the pharmaceutical industry, including the acetaminophen market. The pandemic led to increased demand for pain relief medications due to the rise in post-operative care and other health issues. However, it also introduced challenges in supply chain management and distribution, which could have temporary effects on pricing and availability[1].

Biopharma and Biotech Industry Trends

While acetaminophen is not a biopharmaceutical, the broader trends in the biopharma and biotech industries can influence the overall pharmaceutical market. Innovations in clinical trial designs, regulatory frameworks, and the rise of precision medicine are expected to shape the future of drug development. These trends could indirectly affect the pricing and market dynamics of traditional pharmaceuticals like acetaminophen[3].

Key Takeaways

  • The global acetaminophen market is valued at USD 9.8 billion in 2022 and is expected to grow to USD 15.2 billion by 2033.
  • The oral route of administration dominates the market.
  • Asia-Pacific, particularly India and China, and North America and Europe are key regions.
  • Regulatory changes and legislative actions could impact pricing strategies.
  • The market is highly competitive with several major pharmaceutical companies involved.

FAQs

1. What is the current market value of the global acetaminophen market? The global acetaminophen market was valued at USD 9.8 billion in 2022[1].

2. What is the projected growth rate of the acetaminophen market? The acetaminophen market is expected to grow at a CAGR of 4.2% from 2023 to 2033[1].

3. Which region dominates the acetaminophen market? The Asia-Pacific region, particularly India and China, and North America and Europe are key regions in the acetaminophen market[1].

4. How do regulatory changes impact the pricing of acetaminophen? Regulatory changes, such as Medicare negotiation and penalties for non-compliance, could reduce manufacturer revenues and influence pricing strategies[4].

5. What are the main drivers of demand for acetaminophen? The main drivers include the increasing prevalence of chronic illnesses and the need for effective pain management, particularly in post-operative care and opioid tolerance management[1].

Cited Sources:

  1. Future Market Insights, "Acetaminophen Market Size, Share, Trends & Outlook - 2033"
  2. AARP, "AARP Report Finds Top 10 Prescription Drug Price Hikes"
  3. TFS CRO, "5 Predictions for the Biopharma and Biotech Industries in 2025"
  4. Avalere, "Drug Pricing Bill Could Reduce Manufacturer Revenue by Over $450B"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.